Inflammatory bowel disease: genes and variants
Explore variant evidence for Inflammatory bowel disease across 8 analyzed proteins (IL10RA, NOD2, IL10, IL23R, BACH2 and 3 more). Linked ClinVar records include 7 pathogenic or likely pathogenic variants, 194 variants of uncertain significance and 27 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Inflammatory bowel disease
IL10RA: Interleukin-10 receptor subunit alpha
It is required for cells to respond to the anti-inflammatory cytokine IL-10 and activate downstream STAT3 signaling. Biallelic loss-of-function variants cause severe infantile or very-early-onset inflammatory bowel disease, often with perianal disease and systemic inflammation.
7 ClinVar pathogenic / likely pathogenic and 157 uncertain variants in IL10RA have source records linked to Inflammatory bowel disease. Association strength is not clinical gene validity.
NOD2: Nucleotide-binding oligomerization domain-containing protein 2
It detects bacterial muramyl dipeptide in the cytosol and activates antimicrobial and inflammatory responses. Common loss-of-function variants strongly increase Crohn-disease susceptibility, whereas distinct gain-of-function variants cause Blau syndrome.
0 ClinVar pathogenic / likely pathogenic and 17 uncertain variants in NOD2 have source records linked to Inflammatory bowel disease. Association strength is not clinical gene validity.
IL10: Interleukin-10
It suppresses excessive inflammatory cytokine production and restrains antigen-presenting cells and effector lymphocytes, protecting tissues from immune-mediated damage. Loss of IL-10 signaling causes severe early-onset intestinal inflammation and inflammatory bowel disease.
0 ClinVar pathogenic / likely pathogenic and 44 uncertain variants in IL10 have source records linked to Inflammatory bowel disease. Association strength is not clinical gene validity.
IL23R: Interleukin-23 receptor
It enables lymphocytes to respond to IL-23 and maintain Th17-type inflammatory programs. Common variants can strongly modify inflammatory bowel disease risk, and therapeutic interruption of IL-23 signaling is effective in several immune-mediated disorders.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IL23R have source records linked to Inflammatory bowel disease. Association strength is not clinical gene validity.
BACH2: Transcription regulator protein BACH2
It controls transcriptional programs that balance lymphocyte differentiation, immune tolerance, and effector-cell development. Haploinsufficiency can cause immunodeficiency with autoimmunity, and common variation influences susceptibility to several autoimmune diseases.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in BACH2 have source records linked to Inflammatory bowel disease. Association strength is not clinical gene validity.
CD40: Tumor necrosis factor receptor superfamily member 5
Its engagement on B cells and antigen-presenting cells promotes antibody class switching, germinal-center responses, and broader adaptive immune activation. Loss-of-function variants can cause hyper-IgM immunodeficiency, while excessive signaling contributes to autoimmunity and inflammation.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CD40 have source records linked to Inflammatory bowel disease. Association strength is not clinical gene validity.
IL12B: Interleukin-12 subunit beta
It provides the p40 subunit shared by IL-12 and IL-23, linking innate immune activation to Th1 and Th17 responses. Biallelic loss-of-function variants impair IFN-gamma-mediated defense against mycobacteria and Salmonella, while therapeutic blockade is effective in several inflammatory diseases.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IL12B have source records linked to Inflammatory bowel disease. Association strength is not clinical gene validity.
JAK2: Tyrosine-protein kinase JAK2
It transmits signals from erythropoietin, thrombopoietin, growth hormone, and other cytokine receptors into STAT-dependent transcription. The V617F gain-of-function variant is a major driver of polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in JAK2 have source records linked to Inflammatory bowel disease. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ABCB1 and KRT8.
Where Inflammatory bowel disease variants cluster
- IL10RA Extracellular (positions 22–235): 6 of 7 ClinVar pathogenic / likely pathogenic variants, 2.3× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Inflammatory bowel disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| IL10RA R101W | 101 | Extracellular | Pathogenic / likely pathogenic (★★) |
| IL10RA R117C | 117 | Extracellular | Pathogenic / likely pathogenic (★) |
| IL10RA Y157C | 157 | Extracellular | Pathogenic / likely pathogenic (★) |
| IL10RA I169T | 169 | Extracellular | Pathogenic / likely pathogenic (★) |
| IL10RA R262C | 262 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| IL10RA T84I | 84 | Extracellular | Pathogenic / likely pathogenic |
| IL10RA G141R | 141 | Extracellular | Pathogenic / likely pathogenic |
Diseases related to Inflammatory bowel disease
- Crohn disease, also linked to IL10, IL12B, IL23R, JAK2 and 1 more
- Type 1 diabetes mellitus, also linked to BACH2 and IL10
- Hyper-IgM syndrome, also linked to CD40
- Acute myeloid leukemia, also linked to JAK2
- Autoinflammatory syndrome, also linked to NOD2
- Blau syndrome, also linked to NOD2
- Thrombocythemia, also linked to JAK2
- Essential thrombocythemia, also linked to JAK2
- Hypothyroidism, also linked to BACH2
- Basal cell carcinoma, also linked to BACH2
- Primary myelofibrosis, also linked to JAK2
- Systemic lupus erythematosus, also linked to IL10
Frequently asked questions
Which genes have records linked to Inflammatory bowel disease?
This view contains 8 analyzed proteins: IL10RA, NOD2, IL10, IL23R, BACH2 and 3 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 7 pathogenic or likely pathogenic variants, 194 variants of uncertain significance and 27 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 283 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center